Αρχική World News Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in... World News Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours Από Ogkologos - 2 Μαρτίου, 2026 482 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PYNNACLE study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ EMA recommends granting a marketing authorisation for daraxonrasib Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? MOST POPULAR EMA Recommends Extension of Indications for Dabrafenib and Trametinib 6 Μαΐου, 2026 GreaterGood Is Donating Thousands of Masks to Help Animal Shelters Stay... 17 Σεπτεμβρίου, 2020 Using Artificial Intelligence to Classify Lung Cancer Types, Predict Mutations 10 Οκτωβρίου, 2018 Addressing the Challenges of Cancer Misinformation on Social Media 9 Σεπτεμβρίου, 2021 Φόρτωση περισσοτέρων HOT NEWS How I Found a Meaningful Career After Cancer One year on: How has COVID-19 affected cancer services? Pruebas genéticas para el cáncer en familias: Preguntas y respuestas con... Advances in Treating Kidney Cancer and Metastatic Prostate Cancer: Research from...